FDA Approves Mentor MemoryGel BOOST Breast Implant

The Mentor® MemoryGel BOOST™ Breast Implant is now FDA approved for breast augmentation in women at least 22-years-old, and for women of all ages undergoing breast reconstruction. The product from Mentor Worldwide LLC will be commercially available for surgeons in the US early this year. 

MemoryGel BOOST™ features Mentor’s proprietary highly cohesive gel, an innovative implant shell design, and precision fill ratio, to create an implant with increased form stability to shape the breast.  

According to a recent survey, patients and surgeons both preferred the Mentor MemoryGel BOOST™ Breast Implant as feeling more like a natural breast versus another leading brand.

“Our commitment to innovation is driven, first and foremost, by the needs of our customers and patients, and providing them with the highest quality products to achieve their desired outcome,” says Lori Tierney, Worldwide President, Mentor Worldwide LLC. “With this pivotal addition to our MemoryGel® portfolio, we are thrilled to provide a meaningful range of options to meet surgeon objectives and patient preferences, beyond what is currently available in the breast aesthetics market.”

“Through science-based design and innovation, we are able to offer both increased form stability and a natural feel in the same product,” says Krasimira Hristov, Director of R&D, Mentor Worldwide LLC. “The MemoryGel BOOST™ Breast Implant is truly a unique innovation that satisfies an unmet need and expands the MemoryGel® product line.”